Adjuvant treatment of GIST with imatinib: Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS)

Alessandro Gronchi; Ian Judson; Toshirou Nishida; Andres Poveda; Javier Martin; Peter Reichardt; Paolo G. Casali; Axel Le Cesne; Peter Hohenberger; Jean Yves Blay

doi:10.1016/j.ejca.2009.02.009

Adjuvant treatment of GIST with imatinib: Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS)

Alessandro Gronchi, Ian Judson, Toshirou Nishida, Andres Poveda, Javier Martin, Peter Reichardt, Paolo G. Casali, Axel Le Cesne, Peter Hohenberger, Jean Yves Blay

Research output: Contribution to journal › Comment/debate

28 Citations (Scopus)

Original language	English
Pages (from-to)	1103-1106
Number of pages	4
Journal	European Journal of Cancer
Volume	45
Issue number	7
DOIs	https://doi.org/10.1016/j.ejca.2009.02.009
Publication status	Published - 1 Jan 2009

Access to Document

10.1016/j.ejca.2009.02.009

Cite this

Gronchi, A., Judson, I., Nishida, T., Poveda, A., Martin, J., Reichardt, P., Casali, P. G., Cesne, A. L., Hohenberger, P., & Blay, J. Y. (2009). Adjuvant treatment of GIST with imatinib: Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS). European Journal of Cancer, 45(7), 1103-1106. https://doi.org/10.1016/j.ejca.2009.02.009

Gronchi, Alessandro ; Judson, Ian ; Nishida, Toshirou et al. / Adjuvant treatment of GIST with imatinib : Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS). In: European Journal of Cancer. 2009 ; Vol. 45, No. 7. pp. 1103-1106.

@article{5902da89a28049fd83a3bee4db1266fa,

title = "Adjuvant treatment of GIST with imatinib: Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS)",

author = "Alessandro Gronchi and Ian Judson and Toshirou Nishida and Andres Poveda and Javier Martin and Peter Reichardt and Casali, {Paolo G.} and Cesne, {Axel Le} and Peter Hohenberger and Blay, {Jean Yves}",

year = "2009",

month = jan,

day = "1",

doi = "10.1016/j.ejca.2009.02.009",

language = "English",

volume = "45",

pages = "1103--1106",

journal = "European Journal of Cancer",

issn = "0959-8049",

number = "7",

}

Gronchi, A, Judson, I, Nishida, T, Poveda, A, Martin, J, Reichardt, P, Casali, PG, Cesne, AL, Hohenberger, P & Blay, JY 2009, 'Adjuvant treatment of GIST with imatinib: Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS)', European Journal of Cancer, vol. 45, no. 7, pp. 1103-1106. https://doi.org/10.1016/j.ejca.2009.02.009

Adjuvant treatment of GIST with imatinib: Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS). / Gronchi, Alessandro; Judson, Ian; Nishida, Toshirou et al.
In: European Journal of Cancer, Vol. 45, No. 7, 01.01.2009, p. 1103-1106.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Adjuvant treatment of GIST with imatinib

T2 - Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS)

AU - Gronchi, Alessandro

AU - Judson, Ian

AU - Nishida, Toshirou

AU - Poveda, Andres

AU - Martin, Javier

AU - Reichardt, Peter

AU - Casali, Paolo G.

AU - Cesne, Axel Le

AU - Hohenberger, Peter

AU - Blay, Jean Yves

PY - 2009/1/1

Y1 - 2009/1/1

UR - http://www.scopus.com/inward/record.url?scp=62849115588&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2009.02.009

DO - 10.1016/j.ejca.2009.02.009

M3 - Comment/debate

C2 - 19286368

AN - SCOPUS:62849115588

SN - 0959-8049

VL - 45

SP - 1103

EP - 1106

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 7

ER -

Gronchi A, Judson I, Nishida T, Poveda A, Martin J, Reichardt P et al. Adjuvant treatment of GIST with imatinib: Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS). European Journal of Cancer. 2009 Jan 1;45(7):1103-1106. doi: 10.1016/j.ejca.2009.02.009

Access to Document

Other files and links

Cite this